KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Change in Receivables (2016 - 2025)

Zimmer Biomet Holdings has reported Change in Receivables over the past 17 years, most recently at $111.7 million for Q4 2025.

  • Quarterly results put Change in Receivables at $111.7 million for Q4 2025, up 125.2% from a year ago — trailing twelve months through Dec 2025 was $127.3 million (up 41.92% YoY), and the annual figure for FY2025 was $127.3 million, up 41.92%.
  • Change in Receivables for Q4 2025 was $111.7 million at Zimmer Biomet Holdings, up from -$3.0 million in the prior quarter.
  • Over the last five years, Change in Receivables for ZBH hit a ceiling of $111.7 million in Q4 2025 and a floor of -$34.8 million in Q1 2021.
  • Median Change in Receivables over the past 5 years was $20.8 million (2024), compared with a mean of $24.7 million.
  • Biggest five-year swings in Change in Receivables: skyrocketed 1157.69% in 2022 and later crashed 2183.33% in 2024.
  • Zimmer Biomet Holdings' Change in Receivables stood at $38.8 million in 2021, then skyrocketed by 80.93% to $70.2 million in 2022, then dropped by 3.99% to $67.4 million in 2023, then dropped by 26.41% to $49.6 million in 2024, then surged by 125.2% to $111.7 million in 2025.
  • The last three reported values for Change in Receivables were $111.7 million (Q4 2025), -$3.0 million (Q3 2025), and -$200000.0 (Q2 2025) per Business Quant data.